WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety
Phase 3
Completed
- Conditions
- Surgery--ComplicationsPerioperative/Postoperative ComplicationsSurgery
- Interventions
- Device: Anesthesia Control Tower monitoring
- First Posted Date
- 2019-04-23
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 79560
- Registration Number
- NCT03923699
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Phase 1
Recruiting
- Conditions
- Cutaneous Angiosarcoma
- Interventions
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03921008
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
e-Mindfulness for Depression in Older Adults
Not Applicable
Completed
- Conditions
- DepressionMental Health Disorder
- Interventions
- Behavioral: Mindful My Way
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 31
- Registration Number
- NCT03922217
- Locations
- 🇺🇸
Washington University School of Medicine, Health Mind Lab, Saint Louis, Missouri, United States
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
Phase 2
Active, not recruiting
- Conditions
- Stage IIB Non-Small Cell Lung CancerStage IIIC Non-Small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer
- Interventions
- Device: ViewRay MR-Linear AcceleratorRadiation: Radiation therapy
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT03916419
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS
Not Applicable
Withdrawn
- Conditions
- CancerHIV/AIDS
- Interventions
- Behavioral: Combination intervention
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT03916783
- Locations
- 🇺🇬
International Center for Child Health and Development, Masaka, Uganda
Expanded Access Neoantigen Vaccine in Solid Tumors
- Conditions
- Solid Tumor, Adult
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT03914872
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery
Not Applicable
Terminated
- Conditions
- Soft Tissue Sarcoma
- Interventions
- Other: ExerciseOther: Enhanced Recovery after surgeryOther: Psychological screening with counselling services as neededOther: Dietary Counseling Services
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT03916796
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Non-Operative Management and Early Response Assessment in Rectal Cancer
Not Applicable
Active, not recruiting
- Conditions
- Adenocarcinoma of the Lower Rectum
- Interventions
- Radiation: Radiation therapyDrug: FOLFOX regimenOther: Functional Assessment of Cancer Therapy-Colorectal cancer (FACT-C) questionnaireProcedure: Rectal biopsy samplesProcedure: Blood for ctDNA
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 63
- Registration Number
- NCT03904043
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
Phase 2
Terminated
- Conditions
- Melanoma With Brain Metastasis
- Interventions
- Device: OptuneBiological: NivolumabBiological: Ipilimumab
- First Posted Date
- 2019-04-04
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT03903640
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
LULUN PROJECT II - Cohort Follow-up Study
Completed
- Conditions
- Stunting
- Interventions
- Other: Egg
- First Posted Date
- 2019-04-03
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 270
- Registration Number
- NCT03902145
- Locations
- 🇪🇨
Universidad San Francisco de Quito, Quito, Pichincha, Ecuador
© Copyright 2025. All Rights Reserved by MedPath